Rizvi, Syed Mohd. Danish
Integral University
4 papers on CoChatORCID 0000-0002-3106-4707
Most cited papers
- Verified
Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment
Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., & Kamal, M. A. (2015) · Saudi Journal of Biological Sciences
Antibiotic Resistance in BacteriaAntibiotic Use and Resistance
Cited by 758
- Verified
Invokana (Canagliflozin) as a Dual Inhibitor of Acetylcholinesterase and Sodium Glucose Co-Transporter 2: Advancement in Alzheimer’s Disease- Diabetes Type 2 Linkage via an Enzoinformatics Study
Rizvi, S., Shakil, S., Biswas, D., Shakil, S., Shaikh, S., Bagga, P., & Kamal, M. (2014) · CNS & Neurological Disorders - Drug Targets
Cholinesterase and Neurodegenerative DiseasesComputational Drug Discovery Methods
Cited by 71
- Verified
Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders
Shaikh, S., Rizvi, S. M. D., Shakil, S., Riyaz, S., Biswas, D., & Jahan, R. (2016) · Biotechnology and Applied Biochemistry
Cholinesterase and Neurodegenerative DiseasesComputational Drug Discovery Methods
Cited by 70
- Verified
Predictionof Anti-Diabetic Drugs as Dual Inhibitors Against Acetylcholinesterase and Beta-Secretase: A Neuroinformatics Study
Shaikh, S., Rizvi, S. M., Suhail, T., Shakil, S., Abuzenadah, A., Anis, R., Naaz, D., Dallol, A., Haneef, M., Ahmad, A., et al. (2016) · CNS & Neurological Disorders - Drug Targets
Cholinesterase and Neurodegenerative DiseasesComputational Drug Discovery Methods
Cited by 10
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free